- Home
- COGT vs GOOD Comparison
COGT vs GOOD Comparison
Compare COGT & GOOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- GOOD
- Stock Information
- Founded
- COGT 2014
- GOOD 2003
- Country
- COGT United States
- GOOD United States
- Employees
- COGT 205
- GOOD N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- GOOD Real Estate Investment Trusts
- Sector
- COGT Health Care
- GOOD Real Estate
- Exchange
- COGT Nasdaq
- GOOD Nasdaq
- Market Cap
- COGT 822.0M
- GOOD 670.2M
- IPO Year
- COGT 2018
- GOOD N/A
- Fundamental
- Price
- COGT $7.23
- GOOD $14.38
- Analyst Decision
- COGT Buy
- GOOD Hold
- Analyst Count
- COGT 6
- GOOD 1
- Target Price
- COGT $15.20
- GOOD $15.00
- AVG Volume (30 Days)
- COGT 2.1M
- GOOD 312.2K
- Earning Date
- COGT 08-05-2025
- GOOD 08-05-2025
- Dividend Yield
- COGT N/A
- GOOD 8.36%
- EPS Growth
- COGT N/A
- GOOD N/A
- EPS
- COGT N/A
- GOOD 0.30
- Revenue
- COGT N/A
- GOOD $151,168,000.00
- Revenue This Year
- COGT N/A
- GOOD $4.73
- Revenue Next Year
- COGT N/A
- GOOD $2.84
- P/E Ratio
- COGT N/A
- GOOD $48.68
- Revenue Growth
- COGT N/A
- GOOD 3.01
- 52 Week Low
- COGT $3.72
- GOOD $12.67
- 52 Week High
- COGT $12.61
- GOOD $17.88
- Technical
- Relative Strength Index (RSI)
- COGT 65.40
- GOOD 49.48
- Support Level
- COGT $6.88
- GOOD $14.37
- Resistance Level
- COGT $7.83
- GOOD $14.59
- Average True Range (ATR)
- COGT 0.56
- GOOD 0.22
- MACD
- COGT 0.09
- GOOD -0.01
- Stochastic Oscillator
- COGT 78.17
- GOOD 21.69
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.